The council is comprised of distinguished leaders from various backgrounds and industries, and will provide guidance on matters related to Augmedix’s use of generative AI
Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced the appointment of its inaugural AI Advisory Council members. The council was established to guide Augmedix’s continued development and usage of artificial intelligence (AI) throughout its business responsibly and ethically.
The council is composed of a diverse group of experts, including leading researchers in AI, to advise on the development of new technologies for natural language processing (NLP) and intelligent user interfaces (IUI); bioinformaticians to speak to the appropriate and best use of these technologies in clinical settings; executives from the healthcare systems that will benefit from efficient, structured medical note taking; and professional societies that contribute to government and industrial policies governing AI in healthcare.
The council is led by Joe Marks, Ph.D., a former Augmedix board member who served as director of the Company from 2020 until 2023. Dr. Marks was previously the Executive Director of Carnegie Mellon University’s Center for Machine Learning and Health and has established himself as a technological innovator in seven different industries over the past 30 years.
Council members are esteemed professionals and leaders from various fields and are appointed for 18 months. The newly appointed members of the council are:
- Julia Adler-Milstein, Ph.D., Chief of the Division of Clinical Informatics and Digital Transformation at University of California San Francisco
- Albert Chan, M.D., Chief Digital Health Officer, Sutter Health
- John Chelico, M.D., M.A., FACP, FAMIA, System CMIO for CommonSpirit Health
- John Doulis, M.D., VP Data Services and Technology Innovation at HCA Healthcare
- Jesse Ehrenfeld, M.D., MPH, President of the American Medical Association
- Joe Marks, Ph.D., AI Advisory Council Chair
- Eric Nyberg, Ph.D., Professor at Carnegie Mellon University School of Computer Science Language Technologies Institute
- Lisa Rotenstein, M.D., MBA, MSc, Assistant Professor at Harvard Medical School and Medical Director of Population Health at Brigham and Women’s Hospital
- Sameer Singh, Ph.D., Associate Professor of Computer Science at UC Irvine
- Alex Stinard, M.D., Healthcare Information Technology Consultant at HCA Healthcare
“As Augmedix continues to stay at the forefront of innovation, it is vital that we have meaningful discourse to address potential concerns with the adoption of AI in healthcare,” said Augmedix CEO Manny Krakaris. “The AI Advisory Council will provide our leadership and product innovation teams with evaluations of opportunities and risks of technological advancements in the healthcare space, along with strategic guidance pertaining to our use of generative AI.”
As more healthcare organizations are sharing concerns about the responsible adoption of AI, Augmedix is leading the way with this advisory council to ensure that issues related to transparency, privacy and safety are addressed by a variety of expert perspectives.
“We are thrilled to be working with this group of insightful and experienced thought leaders,” said Marks. “AI technology is evolving rapidly and in surprising ways, so it is important to be informed by all the varied perspectives that we have on the council.”
Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!
